Beta Bionics, Inc. Common Stock (BBNX NASDAQ) stock market data APIs
$26.466
-1.4(-5.3%)
as of November 7, 2025
Try our APIs with
free plan!
Beta Bionics, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes. It has collaboration and license agreement with Xeris Pharmaceuticals, Inc. (Xeris) to develop and commercialize a pump-compatible glucagon formulation; and development and commercialization agreement with Abbott Diabetes Care Inc. to develop and commercialize an automated insulin delivery system. The company was incorporated in 2015 and is based in Irvine, California.
Prev. Close
26.466
Open
25.066
High
26.3978
Low
25.0796
52 wk Range
8.89-30.47
Market Cap
945 M
Shares Outstanding
43 334 K
Revenue
53 034 K
EPS
-0.3256
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Beta Bionics, Inc. Common Stock (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Beta Bionics, Inc. Common Stock data using free add-ons & libraries
Get Beta Bionics, Inc. Common Stock Fundamental Data
Beta Bionics, Inc. Common Stock Fundamental data includes:
- Net Revenue: 53 034 K
- EBITDA: -39 370 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-29
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Beta Bionics, Inc. Common Stock News
New
Beta Bionics raises 2025 revenue guidance to $96.5M and projects Q4 gross margin improvement amid pharmacy channel expansion
Earnings Call Insights: Beta Bionics, Inc. (BBNX) Q3 2025 MANAGEMENT VIEW * CEO Sean Saint opened the call by highlighting "strong performance in the third quarter" and updated annual projections ...
Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance
IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial re...
Stifel resumes coverage on medtech names, sees long-term diabetes devices growth
Investing.com -- Stifel has resumed coverage of several medtech companies, citing steady adoption of continuous glucose monitors (CGMs) and insulin pumps as key drivers for growth. The firm rated Dex...
Goldman Sachs Upgrades Beta Bionics (BBNX) to Buy, Raises PT to $26 on Strong Growth and Market Outlook
Beta Bionics Inc. (NASDAQ:BBNX) is one of the best hot stocks to invest in. On October 1, Goldman Sachs upgraded Beta Bionics to Buy from Neutral with a price target of $26, which was upgraded from $1...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
